Jade Biosciences, Inc. (JBIO)

NASDAQ: JBIO · Real-Time Price · USD

14.42

-0.31 (-2.10%)

Sep 25, 2026, 4:00 PM EDT - Market closed

Jade Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	917	710	-
Market Cap Growth	269.36%	-	-
Enterprise Value	457	512	-
Last Close Price	14.42	15.43	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
PB Ratio	2.08	2.13	-
P/TBV Ratio	2.08	2.13	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	0.00	0.00	-2.30
Net Debt / Equity Ratio	-1.04	-1.01	-0.82
Net Debt / EBITDA Ratio	2.79	2.95	-
Net Debt / FCF Ratio	3.72	3.53	-0.84
Quick Ratio	14.61	20.33	5.78
Current Ratio	14.93	21.09	5.81
Return on Equity (ROE)	-	-89.19%	-
Return on Assets (ROA)	-	-33.59%	-
Return on Capital Employed (ROCE)	-37.40%	-34.10%	-106.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Earnings Yield	-13.57%	-17.95%	-
FCF Yield	-13.47%	-13.37%	-
Buyback Yield / Dilution	-	-893.82%	-